Featured Research

from universities, journals, and other organizations

Two-thirds of women in the U.K. not taking folic acid before pregnancy to prevent spina bifida

Date:
February 19, 2014
Source:
Queen Mary, University of London
Summary:
Less than one in three women have taken folic acid supplements before pregnancy to prevent spina bifida and other birth defects of the brain, spine, or spinal cord (neural tube defects). This is despite research from 1991 showing that such conditions could be prevented in most cases by increasing the intake of the B-vitamin folic acid before pregnancy. Each year in Britain there are about 1,000 pregnancies affected by spina bifida or other birth defects of the brain, spine, or spinal cord. Most of these lead to a termination of pregnancy which is an agonizing decision for couples who want a child.

Research published today from Queen Mary University of London reveals less than 1 in 3 women have taken folic acid supplements before pregnancy to prevent spina bifida and other birth defects of the brain, spine, or spinal cord (neural tube defects). This is despite research from 1991 showing that such conditions could be prevented in most cases by increasing the intake of the B-vitamin folic acid before pregnancy.

The study, carried out by Queen Mary's Wolfson Institute of Preventive Medicine and published in the journal PLOS ONE, questioned nearly half a million women attending antenatal screening between 1999 and 2012 in England and the Isle of Man. The proportion of women taking folic acid supplements decreased from 35% in 1999-2001 to 31% in 2011-2012.

The study also showed strong ethnic variations with only 17% of Afro-Caribbean women, 20% of South Asian women and 25% of East Asian women taking folic acid supplements, compared with 35% of Caucasian women. In addition, only 6% of women under 20 were taking folic acid supplements compared with 40% of women aged 35 to 39.

Women who had previously had a pregnancy involving neural tube defects were more likely to take folic acid supplements before pregnancy than women who had not, but still only half of them did (51%) in spite of their high risk of a recurrence.

Additionally, the proportion of women who started taking folic acid supplements after finding out they were pregnant increased from 45% to 62%. However, for the preventive benefits to be effective, folic acid supplements need to be taken before pregnancy.

"Each year in Britain there are about 1,000 pregnancies affected by spina bifida or other birth defects of the brain, spine, or spinal cord. Most of these lead to a termination of pregnancy which is an agonizing decision for couples who want a child." said Joan Morris, co-author and Professor of Medical Statistics at Queen Mary.

Over 70 countries, including the US and Australia, have introduced mandatory folic acid fortification to reduce the risk of women having a pregnancy affected with neural tube defects. Despite recommendations from the Food Standards Agency to fortify flour with folic acid, and evidence that folic acid fortification is effective, neither the UK nor any other EU country has mandated this.

"The current UK policy of recommending women take folic acid supplements has failed and has also led to health inequalities among ethnic minorities and younger women. The Government should introduce mandatory fortification of flour with folic acid without delay." said Jonathan Bestwick, lead author and Lecturer in Medical Statistics at Queen Mary.

Professor Sir Nicholas Wald, a co-author from Queen Mary, who conducted the original research showing the protective effect of folic acid said: "It's a public health tragedy that in spite of the folic acid fortification initiative in many countries, the UK has not introduced mandatory folic acid fortification. The failure to fortify flour with folic acid is like having a polio vaccine and not using it."


Story Source:

The above story is based on materials provided by Queen Mary, University of London. Note: Materials may be edited for content and length.


Journal Reference:

  1. Jonathan P. Bestwick, Wayne J. Huttly, Joan K. Morris, Nicholas J. Wald. Prevention of Neural Tube Defects: A Cross-Sectional Study of the Uptake of Folic Acid Supplementation in Nearly Half a Million Women. PLoS ONE, 2014; 9 (2): e89354 DOI: 10.1371/journal.pone.0089354

Cite This Page:

Queen Mary, University of London. "Two-thirds of women in the U.K. not taking folic acid before pregnancy to prevent spina bifida." ScienceDaily. ScienceDaily, 19 February 2014. <www.sciencedaily.com/releases/2014/02/140219174853.htm>.
Queen Mary, University of London. (2014, February 19). Two-thirds of women in the U.K. not taking folic acid before pregnancy to prevent spina bifida. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/02/140219174853.htm
Queen Mary, University of London. "Two-thirds of women in the U.K. not taking folic acid before pregnancy to prevent spina bifida." ScienceDaily. www.sciencedaily.com/releases/2014/02/140219174853.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins